IndraLab

Statements

Antagonist inhibits CASP1. 1 / 1

| 1

sparser

"Compstatin was particularly effective in reducing caspase-1 activity, however, also eculizumab and the C5aR antagonist significantly (p < 0.05) inhibited caspase-1 in monocytes suggesting that C5a is a mediator also for CC-induced caspase-1 activation."

24554772

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Antagonist inhibits CASP1. 1 / 1

INDRA sources:

Databases

Reading